-
561505-1GM
L-SELENOMETHIONINE 1PC X 1GM (C005B-032380)
Price: $1,159.60List Price: $1,288.44Increases the expression of glutathione peroxidase. Warning Toxicity: Carcinogenic / Teratogenic (D) Reconstitution Unstable in solution reconstitute just prior to use. -
S1478-100GM
L-Selenomethionine Blend - 100 g
Price: $1,199.56List Price: $1,332.85L-Selenomethionine Blend, also known as MSE, is a naturally occurring amino acid containing selenium and has antioxidant properties. Ungraded products supplied by Spectrum are indicative of a grade suitable for general industrial use or research -
S1478-25GM
L-Selenomethionine Blend - 25 g
Price: $731.47List Price: $812.74L-Selenomethionine Blend, also known as MSE, is a naturally occurring amino acid containing selenium and has antioxidant properties. Ungraded products supplied by Spectrum are indicative of a grade suitable for general industrial use or research -
-
M646551-10mg
MAX-40279 (C007B-374109)
Price: $584.88List Price: $649.86MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)Form:SolidIC50&: Target:FLT3 and FGFR. -
M646551-25mg
MAX-40279 (C007B-374110)
Price: $1,156.50List Price: $1,285.00MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)Form:SolidIC50&: Target:FLT3 and FGFR. -
M646551-50mg
MAX-40279 (C007B-374111)
Price: $1,764.61List Price: $1,960.68MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)Form:SolidIC50&: Target:FLT3 and FGFR. -
M646551-5mg
MAX-40279 (C007B-374112)
Price: $388.92List Price: $432.14MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)Form:SolidIC50&: Target:FLT3 and FGFR. -
M654627-1ml
MAX-40279 (C007B-375443)
Price: $427.70List Price: $475.22MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)IC50&: Target:FLT3 and FGFR. -
18315-10
MCB-613-10 mg
Price: $662.01List Price: $735.57A small molecule stimulator of SRC-1, SRC-2, and SRC-3 that selectively induces paraptosis in a variety of cancer cells in vitro and reduces tumor growth in a xenograft mouse model can increase the interaction of SRCs with the coactivators CBP and -
18315-25
MCB-613-25 mg
Price: $1,236.03List Price: $1,373.36A small molecule stimulator of SRC-1, SRC-2, and SRC-3 that selectively induces paraptosis in a variety of cancer cells in vitro and reduces tumor growth in a xenograft mouse model can increase the interaction of SRCs with the coactivators CBP and -